Monthly Archives: April 2015

On the Skyrocketing Costs
Of MS Drugs: A Patient Point of View

Posted on April 30, 2015 by Laura Newman

Last week, Daniel M. Hartung, PharmD, MPH, and coauthors, published an open-access article in Neurology on astronomical increases in disease-modifying drugs for multiple sclerosis (MS) –many developed decades ago. Notably, they report that first-generation drugs — now cost about $60,000 … Continue reading →

Posted in Drug costs | Tagged , , , , | Comments Off on On the Skyrocketing Costs
Of MS Drugs: A Patient Point of View

Homecare Workers Flood #fightfor15 Rallies,
Wait for President Obama to Act

Posted on April 16, 2015 by Laura Newman

Homecare and direct care workers were out in droves last night in New York’s #fightfor15 rally that stretched from Columbus Circle to Times Square. Initially billed as an event for fast-food and retail workers, the #fightfor15 day expanded to home … Continue reading →

Posted in Uncategorized | Tagged , , | Comments Off on Homecare Workers Flood #fightfor15 Rallies,
Wait for President Obama to Act

Are Pediatric Guidelines for Statins Too Aggressive?

Posted on April 6, 2015 by Laura Newman

If, instead of following the adult guidelines, doctors used pediatric guidelines to identify teens with high LDL-levels, and if universal screening was in place, another 400,000 adolescents would be taking statins. Would that increase be good or bad? Doctors disagree. … Continue reading →

Posted in drugs, pediatrics | Tagged , , | Comments Off on Are Pediatric Guidelines for Statins Too Aggressive?